Evidence map›Paper›PMID 39951485›Full record

ArticlePLoS computational biology2025

Using a multi-strain infectious disease model with physical information neural networks to study the time dependence of SARS-CoV-2 variants of concern.

Wenxuan Li, Xu Chen, Suli Liu, Chiyu Zhang, Guyue Liu

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenxuan LiSchool of Mathematics, Jilin University, Changchun, Jilin, China.
Xu ChenSchool of Artificial Intelligence, Jilin University, Changchun, Jilin, China.
Suli LiuSchool of Mathematics, Jilin University, Changchun, Jilin, China.ORCID 0000-0002-4354-2665
Chiyu ZhangSchool of Mathematics, Jilin University, Changchun, Jilin, China.
Guyue LiuSchool of Mathematics, Jilin University, Changchun, Jilin, China.

Funding

National Natural Science Foundation of ChinaScience and Technology Research Projects of the Education Office of Jilin Province, ChinaTechnology Development Program of Jilin Province, China
6 · The paper itself

Abstract

With the ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its increasing adaptation to humans, several variants of concern (VOCs) and variants of interest (VOIs) have been identified since late 2020. These include Alpha, Beta, Gamma, Delta, Omicron parent lineage, and other variants. These variants may show distinct levels of virulence, antigenicity, and infectivity, which require specific defense and control measures. In this study, we propose an [Formula: see text] infectious disease model to simulate the spread of SARS-CoV-2 variants among the human population. We combine the proposed epidemic model and reported infected data of variants with physical information neural networks (PINNs) to develop a novel mechanism called VOCs-informed neural network (VOCs-INN). In our experiments, we found that this algorithm can accurately fit the reported data of the British Columbia (BC) province and its five internal health agencies in Canada. Furthermore, it can simulate observed or unobserved dynamics, infer time-dependent parameters, and enable short-term predictions. The experimental results also reveal variations in the intensity of control strategies implemented across these regions. VOCs-INN performs well in fitting and forecasting when analyzing long-term or multi-wave data.

Indexed as

COVID-19Models, BiologicalNeural Networks, ComputerSARS-CoV-2AlgorithmsBritish ColumbiaComputational BiologyComputer SimulationHumans

Identifiers

PMID39951485
PMCPMC11828408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.